The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface

Journal of Reproductive Immunology

Volumn 47, Issue 1, 2000, Pages 1-16

  Bainbridge, David R J ^a   Ellis, Shirley A ^b   Sargent, Ian L ^c  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

HLA G; MHC; mRNA splicing; Placenta; Pregnancy

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; HLA G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MESSENGER RNA; MONENSIN;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MUTAGENESIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL; RNA SPLICING; TROPHOBLAST;

BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MONENSIN; PREGNANCY; PREGNANCY PROTEINS; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOLUBILITY; TRANSFECTION;

EID: 0034039871     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(00)00056-5     Document Type: Article

References (46)

1. Allan D.S.J., Colonna M., Lanier L.L. et al. Tetrameric complexes of human histocompatibility leukocyte antigen (HLA-)G bind to peripheral blood myelomonocytic cells. J. Exp. Med. 189:1999;1149-1155.
2. Bainbridge D.R.J, Ellis S.A., Sargent I.L. Little evidence of HLA-G mRNA polymorphism in Caucasian or Afro-Caribbean populations. J. Immunol. 163:1999;2023-2027.
3. Bjorkman P.J., Saper M.A., Samraoui B. et al. Structure of the human class I histocompatibility antigen HLA-A2. Nature. 329:1987;506-512.
4. Braud V.M., Allan D.S.J., Wilson D., McMichael A. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8:1997;1-10.
5. Brickell P.M., Latchman D.S., Murphy D., Willison K., Rigmy P.W.J. Activation of a Qa TLA class I major histocompatibility antigen gene is a general feature of oncogenesis in the mouse. Nature. 306:1983;756-760.
6. Castro M.J., Morales P., Catalfamo M. et al. Lack of HLA-G soluble isoforms in graves-basedow thyrocytes and complete cDNA sequence of the HLA-G*01012 allele. Eur. J. Immunol. 25:1998;311-315.
7. Chu W.J., Fant M.E., Geraghty D.E., Hunt J.S. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts. Hum. Immunol. 59:1998;435-442.
8. Curran M.D., Williams F., Little A.M. et al. Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tiss. Antigens. 53:1999;244-252.
9. Davis D.M., Reyburn H.T., Pazmany L. et al. Impaired spontaneous endocytosis of HLA-G. Eur. J. Immunol. 27:1997;2714-2719.
10. Ellis S.A., Sargent I.L., Redman C.W.G., McMichael A.J. Evidence for a novel HLA antigen found on human extravillous trophoblast and a choriocarcinoma cell line. Immunology. 59:1986;595-601.
11. Ellis S.A., Palmer M.S., McMichael A.J. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J. Immunol. 144:1990;731-735.
12. Farhner K., Hogan B.L.M., Flavell R.A. Transcription of H-2 and Qa genes in embryonic an adult mice. EMBO J. 8:1987;1265-1271.
13. Fournel S., Hue X., Aguerre-Girr M. et al. Purified soluble HLA-G can induce apoptosis of activated CD8+T cells. Placenta. 20:1999;A25.
14. Fujii T., Ishitani A., Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153:1994;5516-5524.
15. Geraghty D.E., Koller B.H., Orr H.T. A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment. Proc. Natl. Acad. Sci. USA. 84:1987;9145-9149.
16. He X., Le J.M. Alternative splicing of HLA class-I transcripts induced by IFN gamma and TNF in fibroblasts - release of soluble HLA-class-I heavy chain and an associated protein. Cell Immunol. 162:1995;159-168.
17. Huang F., Yamaguchi A., Tsuchiya N. et al. Induction of alternative splicing of HLA-B27 by bacterial infection. Arthrit. Rheumat. 40:1997;694-703.
18. Hutter H., Hammer A., Blaschitz A. et al. Expression of HLA class I molecules in human first trimester and term placenta trophoblast. Cell Tiss. Res. 286:1996;439-447.
19. Ishitani A., Geraghty D.E. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc. Natl. Acad. Sci. USA. 89:1992;3947-3951.
20. Ishitani A., Kishida M., Sageshima N. et al. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics. 49:1999;808-811.
21. Jeffrey G.P., Basclain K., Hajek J., Chakrabarti S., Adams P.C. Alternative splicing produces a soluble form of the hereditary hemochromatosis protein HFE. Blood Cell Mol. Dis. 25:1999;61-67.
22. Khalil-Daher I., Riteau B., Menier C. et al. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself. J. Reprod. Immunol. 43:1999;175-182.
23. King A., Boocock C., Sharkey A.M. et al. Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast. J. Immunol. 156:1996;2068-2076.
24. Kirszenbaum M., Moreau P., Teyssier M. et al. Evidence for the presence of the alternatively spliced HLA-G messenger RNA forms in human mononuclear cells from peripheral blood and umbilical cord blood. Human Immunol. 43:1995;237-241.
25. Kirszenbaum M., Moreau P., Gluckman E., Dausset J., Carosella E. An alternatively spliced form of HLA-G messenger RNA in human trophoblasts and evidecen for the presence of HLA-G transcript in adult lymphocytes. Proc. Nat. Acad. Sci. USA. 91:1994;4209-4213.
26. Kovats S., Main E.K., Librach C. et al. A class I antigen, HLA-G, expressed in human trophoblasts. Science. 248:1990;220-223.
27. Krangel M.S. Secretion of HLA-A and HLA-B antigens via an alternative RNA splicing pathway. J. Exp. Med. 163:1986;1173-1190.
28. Lalanne J.L., Transy C., Guerin S. et al. Expression of class I genes in the major histocompatibility complex - identification of eight distinct messenger RNAs in DBA/2 mouse liver. Cell. 41:1985;469-478.
29. Le Bouteiller P., Blaschitz A. The functionality of HLA-G is emerging. Immunol. Rev. 167:1999;233-244.
30. Lee N., Malacko A.R., Ishitani A. et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity. 3:1995;591-600.
31. Lopez A.J. Alternative splicing of pre-mRNA. Ann. Rev. Genet. 23:1998;279-305.
32. Moreau P., Teyssier M., Kirszenbaum M. et al. HLA-G mRNA forms in human trophoblasts and peripheral blood lymphocytes: potential use in prenatal diagnosis. Folia. Biol. Praha. 40:1994;431-438.
33. Moreau P., Carosella E., Teyssier M. et al. Soluble HLA-G molecule. An alternatively spliced HLA-G mRNA form. Human Immunol. 43:1995;231-236.
34. Moreau P., Paul P., Rouass-Freiss N. et al. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft. Am. J. Reprod. Immunol. 40:1998;136-144.
35. Pazmany L., Mandelboim O., Vales-Gomez M. et al. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science. 274:1996;792-795.
36. Rebmann V., Pfeiffer K.A., Päßler M. et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid. Tiss. Antigens. 53:1999;14-22.
37. Riegert P., Wanner V., Bahram S. Genomics, isoforms, expression and phylogeny of the MHC class I-related MR1 gene. J. Immunol. 161:1998;4066-4077.
38. Sanders S.K., Giblin P.A., Kavathas P. Cell-cell adhesion mediated by CD8 and human histocompatibility complex class 1 molecule on cytotrophoblasts. J. Exp. Med. 174:1991;737-740.
39. Shields M.J., Ribaudo R.K. Mapping of the monoclonal antibody W6/32: sensitivity to the amino terminus of (2-microglobulin. Tiss. Antigens. 51:1998;567-570.
40. Tabaczewski P., Shirwan H., Lewis K., Stroynowski I. Alternative splicing of class IB major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood. Proc. Natl. Acad. Sci. USA. 91:1994;1883-1887.
41. Tamaki J., Arimura Y., Koda T. et al. Heterogeneity of HLA-G genes identified by polymerase chain reaction/single strand conformational polymorphism (PCR/SSCP). Microbiol. Immunol. 37:1993;633-640.
42. Ulker N., Lewis K.D., Hood L.E., Stroynowski I. Activated T-cells transcribe an alternatively spliced messenger RNA encoding a soluble form of Qa-2. EMBO J. 9:1990;3839-3847.
43. Wang Z.G., Marincola F.M., Rivoltini L., Parmiani G., Ferrone S. Selective histocompatibility antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells. J. Exp. Med. 190:1999;205-215.
44. Wei X.H., Orr H.T. Differential expression of HLA-E, HLA-F and HLA-G transcripts in human tissue. Hum. Immunol. 29:1990;131-142.
45. Yelavarthi K.K., Fishback J.L., Hunt J.S. Analysis of HLA-G mRNA in human placental and extraplacental membrane cells by in situ hybridization. J. Immunol. 146:1991;2847-2854.
46. Yuan Z., Knechtle S. Two distinct forms of soluble MHC class I molecules synthesized by different mechanisms in normal rat cells in vitro. Hum. Immunol. 59:1998;404-414.